[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global API(Active Pharmaceutical Ingredient) Intermediate Market Research Report 2017

August 2017 | 104 pages | ID: G9FDC161131EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global API(Active Pharmaceutical Ingredient) Intermediate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate in these regions, from 2012 to 2022 (forecast), covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Global API(Active Pharmaceutical Ingredient) Intermediate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
  • Jigs Chemical
  • Sanofi Winthrop Industrie S.A.
  • Shandong Jiulong Fine Chemical Co., Ltd.
  • Hipharma Limited
  • AMPAC Fine Chemicals
  • BASF
  • Cambrex Corporation
  • A R Life Sciences Pvt. Ltd.
  • Dragon Hwa ChemPharm. Co., Ltd.
  • Ami Life Sciences Pvt. Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Product
    • Biotech Intermediates
    • Chemical Intermediates
  • By Type of Intermediate
    • Patent Intermediates
    • Non-patent Intermediates
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of API(Active Pharmaceutical Ingredient) Intermediate for each application, including
  • Oncology
  • Diabetes
  • Endocrinology
  • Cardiovascular Disease
  • CNS & Neurological Disorders
If you have any special requirements, please let us know and we will offer you the report as you want.
Global API(Active Pharmaceutical Ingredient) Intermediate Market Research Report 2017

1 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET OVERVIEW

1.1 Product Overview and Scope of API(Active Pharmaceutical Ingredient) Intermediate
1.2 API(Active Pharmaceutical Ingredient) Intermediate Segment By Product
  1.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production and CAGR (%) Comparison By Product (Product Category)(2012-2022)
  1.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share By Product (Product Category) in 2016
  1.2.3 Biotech Intermediates
  1.2.4 Chemical Intermediates
1.3 API(Active Pharmaceutical Ingredient) Intermediate Segment By Type of Intermediate
  1.3.1 Patent Intermediates
  1.3.2 Non-patent Intermediates
1.4 Global API(Active Pharmaceutical Ingredient) Intermediate Segment by Application
  1.4.1 API(Active Pharmaceutical Ingredient) Intermediate Consumption (Sales) Comparison by Application (2012-2022)
  1.4.2 Oncology
  1.4.3 Diabetes
  1.4.4 Endocrinology
  1.4.5 Cardiovascular Disease
  1.4.6 CNS & Neurological Disorders
1.5 Global API(Active Pharmaceutical Ingredient) Intermediate Market by Region (2012-2022)
  1.5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.5.2 North America Status and Prospect (2012-2022)
  1.5.3 Europe Status and Prospect (2012-2022)
  1.5.4 China Status and Prospect (2012-2022)
  1.5.5 Japan Status and Prospect (2012-2022)
  1.5.6 Southeast Asia Status and Prospect (2012-2022)
  1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of API(Active Pharmaceutical Ingredient) Intermediate (2012-2022)
  1.6.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Status and Outlook (2012-2022)
  1.6.2 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET COMPETITION BY MANUFACTURERS

2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production and Share by Manufacturers (2012-2017)
2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Share by Manufacturers (2012-2017)
2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Average Price by Manufacturers (2012-2017)
2.4 Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution, Sales Area and Product Type
2.5 API(Active Pharmaceutical Ingredient) Intermediate Market Competitive Situation and Trends
  2.5.1 API(Active Pharmaceutical Ingredient) Intermediate Market Concentration Rate
  2.5.2 API(Active Pharmaceutical Ingredient) Intermediate Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity and Market Share by Region (2012-2017)
3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production and Market Share by Region (2012-2017)
3.3 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Region (2012-2017)
4.2 North America API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export, Import (2012-2017)
4.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export, Import (2012-2017)
4.4 China API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export, Import (2012-2017)
4.5 Japan API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export, Import (2012-2017)
4.7 India API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export, Import (2012-2017)

5 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production and Market Share by Type (2012-2017)
5.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Market Share by Type (2012-2017)
5.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price by Type (2012-2017)
5.4 Global API(Active Pharmaceutical Ingredient) Intermediate Production Growth by Type (2012-2017)

6 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET ANALYSIS BY APPLICATION

6.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption and Market Share by Application (2012-2017)
6.2 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MANUFACTURERS PROFILES/ANALYSIS

7.1 Jigs Chemical
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Sanofi Winthrop Industrie S.A.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Shandong Jiulong Fine Chemical Co., Ltd.
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Hipharma Limited
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 AMPAC Fine Chemicals
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 BASF
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Cambrex Corporation
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 A R Life Sciences Pvt. Ltd.
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Dragon Hwa ChemPharm. Co., Ltd.
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Ami Life Sciences Pvt. Ltd.
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 API(Active Pharmaceutical Ingredient) Intermediate Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MANUFACTURING COST ANALYSIS

8.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL API(ACTIVE PHARMACEUTICAL INGREDIENT) INTERMEDIATE MARKET FORECAST (2017-2022)

12.1 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price and Trend Forecast (2017-2022)
12.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global API(Active Pharmaceutical Ingredient) Intermediate Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of API(Active Pharmaceutical Ingredient) Intermediate
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Biotech Intermediates
Table Major Manufacturers of Biotech Intermediates
Figure Product Picture of Chemical Intermediates
Table Major Manufacturers of Chemical Intermediates
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) by Applications (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Applications in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS & Neurological Disorders Examples
Table Key Downstream Customer in CNS & Neurological Disorders
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Market Size (Million USD), Comparison (K MT) and CAGR (%) by Regions (2012-2022)
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT) Status and Outlook (2012-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Major Players Product Capacity (K MT) (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Capacity (K MT) of Key Manufacturers (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity (K MT) of Key Manufacturers in 2016
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity (K MT) of Key Manufacturers in 2017
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Major Players Product Production (K MT) (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) of Key Manufacturers (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers (2012-2017)
Figure 2016 API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers
Figure 2017 API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Major Players Product Revenue (Million USD) (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Manufacturers (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2012-2017)
Table 2016 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers
Table 2017 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers
Table Global Market API(Active Pharmaceutical Ingredient) Intermediate Average Price (USD/MT) of Key Manufacturers (2012-2017)
Figure Global Market API(Active Pharmaceutical Ingredient) Intermediate Average Price (USD/MT) of Key Manufacturers in 2016
Table Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution and Sales Area
Table Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Product Category
Figure API(Active Pharmaceutical Ingredient) Intermediate Market Share of Top 3 Manufacturers
Figure API(Active Pharmaceutical Ingredient) Intermediate Market Share of Top 5 Manufacturers
Table Global API(Active Pharmaceutical Ingredient) Intermediate Capacity (K MT) by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity Market Share by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity Market Share by Region (2012-2017)
Figure 2016 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity Market Share by Region
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Region (2012-2017)
Figure 2016 Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Region
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Region (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2012-2017)
Table 2016 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT) and Growth Rate (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table North America API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table China API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table India API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) Market by Region (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Region (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Region (2012-2017)
Figure 2016 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) Market Share by Region
Table North America API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import & Export (K MT) (2012-2017)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import & Export (K MT) (2012-2017)
Table China API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import & Export (K MT) (2012-2017)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import & Export (K MT) (2012-2017)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import & Export (K MT) (2012-2017)
Table India API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Import & Export (K MT) (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Type (2012-2017)
Figure Production Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2012-2017)
Figure 2016 Production Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2012-2017)
Figure Production Revenue Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2012-2017)
Figure 2016 Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type
Table Global API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) by Type (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Growth by Type (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) by Application (2012-2017)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Applications (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application in 2016
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Growth Rate by Application (2012-2017)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Growth Rate by Application (2012-2017)
Table Jigs Chemical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Sanofi Winthrop Industrie S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Shandong Jiulong Fine Chemical Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Hipharma Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table AMPAC Fine Chemicals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table BASF Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BASF API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Cambrex Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table A R Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Dragon Hwa ChemPharm. Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Ami Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share (2012-2017)
Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of API(Active Pharmaceutical Ingredient) Intermediate
Figure Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate
Figure API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis
Table Raw Materials Sources of API(Active Pharmaceutical Ingredient) Intermediate Major Manufacturers in 2016
Table Major Buyers of API(Active Pharmaceutical Ingredient) Intermediate
Table Distributors/Traders List
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Price (Million USD) and Trend Forecast (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) Forecast by Region (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share Forecast by Region (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) Forecast by Region (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share Forecast by Region (2017-2022)
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and Growth Rate Forecast (2017-2022)
Figure North America API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and Growth Rate Forecast (2017-2022)
Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) and Growth Rate Forecast (2017-2022)
Figure India API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India API(Active Pharmaceutical Ingredient) Intermediate Production, Consumption, Export and Import (K MT) Forecast (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) Forecast by Type (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production (K MT) Forecast by Type (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Type (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Price Forecast by Type (2017-2022)
Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) Forecast by Application (2017-2022)
Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

More Publications

Need Help?

Ask a Question

Market Reports

All Categories